Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
Nimansha Jain, Caroline A. Lewis, Jason D. Ulrich, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Role of neuroinflammation in neurodegeneration development
Weifeng Zhang, Dan Xiao, Qinwen Mao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 522
Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 183
The effects of microglia-associated neuroinflammation on Alzheimer’s disease
Cuicui Wang, Shuai Zong, Xiaolin Cui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 124
Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer’s disease
Zhuoran Yin, Shawn Herron, Sebastian Silveira, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 7, pp. 1196-1207
Closed Access | Times Cited: 59
Identification of senescent, TREM2-expressing microglia in aging and Alzheimer’s disease model mouse brain
Noa Rachmian, Sedi Medina, Ulysse Cherqui, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 6, pp. 1116-1124
Closed Access | Times Cited: 51
APOE3ch alters microglial response and suppresses Aβ-induced tau seeding and spread
Yun Chen, Sihui Song, Samira Parhizkar, et al.
Cell (2023) Vol. 187, Iss. 2, pp. 428-445.e20
Open Access | Times Cited: 47
Chronic effects of inflammation on tauopathies
Connor Langworth-Green, Saisha Patel, Zane Jaunmuktane, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 5, pp. 430-442
Open Access | Times Cited: 43
Emerging role of senescent microglia in brain aging-related neurodegenerative diseases
Chan Rim, Min-Jung You, Minyeop Nahm, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Cellular and pathological functions of tau
C Bravo, Sarah Naguib, Li Gan
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 11, pp. 845-864
Closed Access | Times Cited: 34
Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies
Paras S. Minhas, Jeffrey R. Jones, Amira Latif‐Hernandez, et al.
Science (2024) Vol. 385, Iss. 6711
Open Access | Times Cited: 26
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer’s disease
Miguel Angel Abellanas, Maitreyee Purnapatre, Chiara Burgaletto, et al.
Nature Neuroscience (2025)
Closed Access | Times Cited: 2
Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer’s disease
Xingyu Zhang, Li Tang, Jiaolong Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 36
The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
Jacob Deyell, Manjari Sriparna, Mingyao Ying, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2477-2477
Open Access | Times Cited: 33
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 25
APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading
Chanung Wang, Aishwarya Nambiar, Michael R. Strickland, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 22
Current views on meningeal lymphatics and immunity in aging and Alzheimer’s disease
Shanon Rego, Guadalupe Sánchez, Sandro Dá Mesquita
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy
Jinwang Ye, Hua-Li Wan, Sihua Chen, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1489-1498
Open Access | Times Cited: 22
Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Jinchao Hou, Yun Chen, Zhangying Cai, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 741
Closed Access | Times Cited: 14
Updates in Alzheimer's disease: from basic research to diagnosis and therapies
Enjie Liu, Yao Zhang, Jian–Zhi Wang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Alzheimer’s disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model
Gillian Carling, Li Fan, Nessa R. Foxe, et al.
Neuron (2024) Vol. 112, Iss. 23, pp. 3877-3896.e8
Open Access | Times Cited: 12
Microglia and TREM2
Jennifer M. Pocock, Foteini Vasilopoulou, Elina Svensson, et al.
Neuropharmacology (2024) Vol. 257, pp. 110020-110020
Closed Access | Times Cited: 11
TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models
Edward N. Wilson, Congcong Wang, Michelle S. Swarovski, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 5, pp. 873-885
Open Access | Times Cited: 10
Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer’s disease
Hua Long, Adam Simmons, Arthur J. Mayorga, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges
Emilia Zgórzyńska
Molecular and Cellular Neuroscience (2024) Vol. 128, pp. 103917-103917
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top